Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. F. Parrott
Hormonal Effects of Apomorphine and Cholecystokinin in Pigs: Modification of the Response to Cholecystokinin by a Dopamine Antagonist (Metoclopramide) and a Kappa Opioid Agonist (PD117302)
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Endocrine and Behavioural Factors Affecting Water Balance in Sheep Subjected to Isolation Stress
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Related publications
Heteromerization of Μ-Opioid Receptor and Cholecystokinin B Receptor Through the Third Transmembrane Domain of the Μ-Opioid Receptor Contributes to the Anti-Opioid Effects of Cholecystokinin Octapeptide
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Study of a Structurally Similar Kappa Opioid Receptor Agonist and Antagonist Pair by Molecular Dynamics Simulations
Journal of Molecular Modeling
Organic Chemistry
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Mathematics
Computational Theory
Catalysis
Physical
Effects of a Cholecystokinin Receptor Antagonist on Intestinal Phase of Pancreatic and Biliary Responses in Man.
Journal of Clinical Investigation
Medicine
Effects of Spiradoline Mesylate, a Selective .KAPPA.-Opioid-Receptor Agonist, on the Central Dopamine System With Relation to Mouse Locomotor Activity and Analgesia.
The Japanese Journal of Pharmacology
Physiological Role of Cholecystokinin on Postprandial Insulin Secretion and Gastric Meal Emptying in Man. Studies With the Cholecystokinin Receptor Antagonist Loxiglumide
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Synthesis of Constrained Analogues of Cholecystokinin/Opioid Chimeric Peptides
Tetrahedron Letters
Organic Chemistry
Biochemistry
Drug Discovery
Cholecystokinin Potentiates Dopamine-Mediated Behaviors: Evidence for Modulation Specific to a Site of Coexistence
Journal of Neuroscience
Neuroscience
Elimination of a Cholecystokinin Receptor Agonist ‘Trigger’ in an Effort to Develop Positive Allosteric Modulators Without Intrinsic Agonist Activity
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Cholecystokinin Receptor-1 Mediates the Inhibitory Effects of Exogenous Cholecystokinin Octapeptide on Cellular Morphine Dependence
BMC Neuroscience
Neuroscience
Cellular
Molecular Neuroscience
